Please assess the completion status of the following clinical trial:

Trial Title: Pain Medicine for Wound Care Procedures

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adults patients (≥ 21 years) have to have an open wound with duration of no more than 10 days that requires wound care~* be able to self-report their pain~* had a pain intensity score \> 3 during previous wound care procedure~* has intravenous access~Exclusion Criteria:~* Patients with an injury that impairs sensation in the wound area according to a medical diagnosis~* has an allergy to morphine or ketamine~* has not received morphine previously~* In addition, patients who are 65 years of age or older.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Morphine plus Ketamine, then Morphine plus Saline (placebo) (Type: ACTIVE_COMPARATOR): During the first wound care procedure, patients received morphine 0.05 mg/kg (a maximum dose of 4 mg) plus ketamine 0.25 mg/kg (MK). Then, during the second wound care procedure, patients received morphine 0.1 mg/kg (a maximum dose of 8 mg) plus saline (MS).
- Morphine plus Saline (placebo), then Morphine plus Ketamine (Type: PLACEBO_COMPARATOR): During the first wound care procedure, patients received morphine 0.1 mg/kg (a maximum dose of 8 mg) plus saline (MS). Then, during the second wound care procedure, patients received morphine 0.05 mg/kg (a maximum dose of 4mg) plus ketamine 0.25 mg/kg (MK)

Based on this trial design, predict the completion outcome and termination type (if applicable).